‪T Ciulla, TA Ciulla, Thomas Ciulla‬

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	30997	9318
h-endeksi	81	51
i10-endeksi	207	138

2100

1050

525

1575

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202593 132 193 232 330 498 584 624 711 620 589 902 1193 1497 1670 1958 2048 1850 1703 1544 1470 1704 1992 1907 1619 1753 223

Genel erişim

Tümünü görüntüle

51 makale

2 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Alon HarrisIcahn School of Medicine at Mount Sinaimssm.edu üzerinde doğrulanmış e-posta adresine sahip
Ronald P DanisUniversity of Wisconsin School of Medicine and Public Healthwisc.edu üzerinde doğrulanmış e-posta adresine sahip
Peter CampochiaroEccles Professor of Ophthalmology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MDjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Jeffrey Heiereyeboston.com üzerinde doğrulanmış e-posta adresine sahip
Gui-shuang YingCarolyn F. Jones Professor of Ophthalmologypennmedicine.upenn.edu üzerinde doğrulanmış e-posta adresine sahip
Cynthia TothProfessor of Ophthalmology, Duke Universityduke.edu üzerinde doğrulanmış e-posta adresine sahip
David M Brown MD FACSDirector of Research, Retina Consultants of Houstonhoustonretina.com üzerinde doğrulanmış e-posta adresine sahip
Brent SieskyIcahn School of Medicine at Mount Sinaimssm.edu üzerinde doğrulanmış e-posta adresine sahip
L KagemannDepartment of Ophthalmology, New York University Langone School of Medicinenyumc.org üzerinde doğrulanmış e-posta adresine sahip
Alice Verticchio VercellinIcahn School of Medicine at Mount Sinaimssm.edu üzerinde doğrulanmış e-posta adresine sahip
Peter KaiserProfessor of Ophthalmology, Cleveland Clinic Lerner College of Medicineccf.org üzerinde doğrulanmış e-posta adresine sahip
Steven YehEmory Eye Center, Emory University School of Medicineemory.edu üzerinde doğrulanmış e-posta adresine sahip
Lloyd Paul Aiello, MD, PhDProfessor of Ophthalmology, Joslin Diabetes Center, Harvard Medical Schooljoslin.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Christopher R. Henry MDRetina Consultants of Houstonhoustonretina.com üzerinde doğrulanmış e-posta adresine sahip
Elia DuhJohns Hopkins University School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Stephen L. HauserUCSFucsf.edu üzerinde doğrulanmış e-posta adresine sahip
Mark R BarakatDirector of Clinical Research, Retina Macula Institute of Arizonaazretinamacula.com üzerinde doğrulanmış e-posta adresine sahip
Rahul N. KhuranaNorthern California Retina Vitreous Associatesncrva.com üzerinde doğrulanmış e-posta adresine sahip
Mark L. Van NattaAssociate Scientist, Johns Hopkins Bloomberg School of Public Healthjhsph.edu üzerinde doğrulanmış e-posta adresine sahip
Julia A. HallerProfessor, Wills Eye, Hopkins, Jeffersonwillseye.org üzerinde doğrulanmış e-posta adresine sahip

Takip et

T Ciulla, TA Ciulla, Thomas Ciulla

Chief Medical Officer, Viridian; Volunteer Clinical Professor, Indiana Univ Schl of Medicine

midwesteye.com üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

AMD Diabetic Retinopathy Autoimmune Disease Gene Therapy Drug Delivery


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results DF Martin, MG Maguire, SL Fine, G Ying, GJ Jaffe, JE Grunwald, C Toth, ... Ophthalmology 119 (7), 1388-1398, 2012	2048	2012
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study DM Brown, M Michels, PK Kaiser, JS Heier, JP Sy, T Ianchulev Ophthalmology 116 (1), 57-65. e5, 2009	1781	2009
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies TA Ciulla, AG Amador, B Zinman Diabetes care 26 (9), 2653-2664, 2003	1279	2003
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study PA Campochiaro, JS Heier, L Feiner, S Gray, N Saroj, AC Rundle, ... Ophthalmology 117 (6), 1102-1112. e1, 2010	1239	2010
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study DM Brown, PA Campochiaro, RP Singh, Z Li, S Gray, N Saroj, AC Rundle, ... Ophthalmology 117 (6), 1124-1133. e1, 2010	1121	2010
Vascular endothelial growth factor–induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform–selective inhibitor LP Aiello, SE Bursell, A Clermont, E Duh, H Ishii, C Takagi, F Mori, ... Diabetes 46 (9), 1473-1480, 1997	950	1997
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study QD Nguyen, SM Shah, AA Khwaja, R Channa, E Hatef, DV Do, D Boyer, ... Ophthalmology 117 (11), 2146-2151, 2010	782	2010
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update TA Ciulla, MB Starr, S Masket Ophthalmology 109 (1), 13-24, 2002	750	2002
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes P Stalmans, MS Benz, A Gandorfer, A Kampik, A Girach, S Pakola, ... New England Journal of Medicine 367 (7), 606-615, 2012	737	2012
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch … IU Scott, MS Ip, PC VanVeldhuisen, NL Oden, BA Blodi, M Fisher, ... Archives of ophthalmology 127 (9), 1115, 2009	717	2009
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central … MS Ip, IU Scott, PC VanVeldhuisen, NL Oden, BA Blodi, M Fisher, ... Archives of ophthalmology 127 (9), 1101, 2009	694	2009
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration RP Danis, TA Ciulla, LM Pratt, W Anliker Retina 20 (3), 244-250, 2000	656	2000
Ranibizumab and bevacizumab for neovascular age-related macular degeneration CATT Research Group New England Journal of Medicine 364 (20), 1897-1908, 2011	632	2011
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration BG Busbee, AC Ho, DM Brown, JS Heier, IJ Suñer, Z Li, RG Rubio, P Lai, ... Ophthalmology 120 (5), 1046-1056, 2013	623	2013
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study JS Heier, AN Antoszyk, PR Pavan, SR Leff, PJ Rosenfeld, TA Ciulla, ... Ophthalmology 113 (4), 633-642. e4, 2006	534	2006
Primary end point (six months) results of the ranibizumab for edema of the macula in diabetes (READ-2) study QD Nguyen, SM Shah, JS Heier, DV Do, J Lim, D Boyer, P Abraham, ... Ophthalmology 116 (11), 2175-2181. e1, 2009	505	2009
Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema PA Campochiaro, DM Brown, A Pearson, T Ciulla, D Boyer, FG Holz, ... Ophthalmology 118 (4), 626-635. e2, 2011	498	2011
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study JS Heier, DS Boyer, TA Ciulla, PJ Ferrone, JM Jumper, RC Gentile, ... Archives of Ophthalmology 124 (11), 1532-1542, 2006	399	2006
Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials GJ Jaffe, DF Martin, CA Toth, E Daniel, MG Maguire, GS Ying, ... Ophthalmology 120 (9), 1860-1870, 2013	306	2013
A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex E Seboun, MA Robinson, TH Doolittle, TA Ciulla, TJ Kindt, SL Hauser Cell 57 (7), 1095-1100, 1989	292	1989

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar